Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
11.58
-3.50 (-23.21%)
At close: Oct 29, 2025, 4:00 PM EDT
11.64
+0.06 (0.52%)
After-hours: Oct 29, 2025, 7:49 PM EDT
Avantor Market Cap
Avantor has a market cap or net worth of $7.89 billion as of October 29, 2025. Its market cap has decreased by -53.66% in one year.
Market Cap
7.89B
Enterprise Value
11.50B
1-Year Change
-53.66%
Ranking
Category
Stock Price
$11.58
Market Cap Chart
Since May 17, 2019, Avantor's market cap has increased from $4.93B to $7.89B, an increase of 60.21%. That is a compound annual growth rate of 7.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 7.89B | -44.95% |
| Dec 31, 2024 | 14.34B | -7.13% |
| Dec 29, 2023 | 15.44B | 8.60% |
| Dec 30, 2022 | 14.22B | -44.64% |
| Dec 31, 2021 | 25.68B | 57.75% |
| Dec 31, 2020 | 16.28B | 56.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |